INTRODUCTION: Leg ulcers usually occur secondary to venous reflux or obstruction, but 20% of people with leg ulcers have arterial disease, with or without venous disorders. Between 1.5 and 3.0 in 1000 people have active leg ulcers. Prevalence increases with age to about 20 in 1000 people aged over 80 years. METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical questions: What are the effects of treatments for venous leg ulcers? What are the effects of organisational interventions for venous leg ulcers? What are the effects of advice about self-help interventions in people receiving usual care for venous leg ulcers? What are the effects of interventions to prevent recurrence of venous leg ulcers? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2014 (Clinical Evidence overviews are updated periodically; please check our website for the most up-to-date version of this overview). RESULTS: At this update, searching of electronic databases retrieved 116 studies. After deduplication and removal of conference abstracts, 63 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 43 studies and the further review of 20 full publications. Of the 20 full articles evaluated, four systematic reviews were updated and four RCTs were added at this update. We performed a GRADE evaluation for 23 PICO combinations. CONCLUSIONS: In this systematic overview, we categorised the efficacy for 13 interventions based on information about the effectiveness and safety of advice to elevate leg, advice to keep leg active, compression stockings for prevention of recurrence, compression bandages and stockings to treat venous leg ulcers, laser treatment (low level), leg ulcer clinics, pentoxifylline, skin grafting, superficial vein surgery for prevention of recurrence, superficial vein surgery to treat venous leg ulcers, therapeutic ultrasound, and topical negative pressure.
INTRODUCTION:Leg ulcers usually occur secondary to venous reflux or obstruction, but 20% of people with leg ulcers have arterial disease, with or without venous disorders. Between 1.5 and 3.0 in 1000 people have active leg ulcers. Prevalence increases with age to about 20 in 1000 people aged over 80 years. METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical questions: What are the effects of treatments for venous leg ulcers? What are the effects of organisational interventions for venous leg ulcers? What are the effects of advice about self-help interventions in people receiving usual care for venous leg ulcers? What are the effects of interventions to prevent recurrence of venous leg ulcers? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2014 (Clinical Evidence overviews are updated periodically; please check our website for the most up-to-date version of this overview). RESULTS: At this update, searching of electronic databases retrieved 116 studies. After deduplication and removal of conference abstracts, 63 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 43 studies and the further review of 20 full publications. Of the 20 full articles evaluated, four systematic reviews were updated and four RCTs were added at this update. We performed a GRADE evaluation for 23 PICO combinations. CONCLUSIONS: In this systematic overview, we categorised the efficacy for 13 interventions based on information about the effectiveness and safety of advice to elevate leg, advice to keep leg active, compression stockings for prevention of recurrence, compression bandages and stockings to treat venous leg ulcers, laser treatment (low level), leg ulcer clinics, pentoxifylline, skin grafting, superficial vein surgery for prevention of recurrence, superficial vein surgery to treat venous leg ulcers, therapeutic ultrasound, and topical negative pressure.
Authors: Pawel Dolibog; Andrzej Franek; Jakub Taradaj; Patrycja Dolibog; Edward Blaszczak; Anna Polak; Ligia Brzezinska-Wcislo; Antoni Hrycek; Tomasz Urbanek; Jacek Ziaja; Magdalena Kolanko Journal: Int J Med Sci Date: 2013-12-14 Impact factor: 3.738
Authors: Vincent Falanga; Roslyn Rivkah Isseroff; Athena M Soulika; Marco Romanelli; David Margolis; Suzanne Kapp; Mark Granick; Keith Harding Journal: Nat Rev Dis Primers Date: 2022-07-21 Impact factor: 65.038
Authors: Yuji Gao; Dat T Nguyen; Trifanny Yeo; Su Bin Lim; Wei Xian Tan; Leigh Edward Madden; Lin Jin; Ji Yong Kenan Long; Fazila Abu Bakar Aloweni; Yi Jia Angela Liew; Mandy Li Ling Tan; Shin Yuh Ang; Sivagame D/O Maniya; Ibrahim Abdelwahab; Kian Ping Loh; Chia-Hung Chen; David Laurence Becker; David Leavesley; John S Ho; Chwee Teck Lim Journal: Sci Adv Date: 2021-05-21 Impact factor: 14.136
Authors: Mateusz Gajda; Emilia Załugowicz; Monika Pomorska-Wesołowska; Tomasz Bochenek; Barbara Gryglewska; Dorota Romaniszyn; Agnieszka Chmielarczyk; Jadwiga Wójkowska-Mach Journal: Int J Environ Res Public Health Date: 2021-04-27 Impact factor: 3.390
Authors: Justyna Cwajda-Białasik; Paulina Mościcka; Arkadiusz Jawień; Maria Teresa Szewczyk Journal: Int J Environ Res Public Health Date: 2021-12-08 Impact factor: 3.390